137496-71-0Relevant articles and documents
The Configuration Stability of Chiral Lithio α-Amino Carbanions. The Effect of Li-O vs. Li-N Complexation.
Elworthy, Todd R.,Meyers, A. I.
, p. 6089 - 6096 (1994)
α-Lithio pyrrolidine, as its N-t-BOC or formamidine derivative, has been generated in high enantiomeric purity via Sn-Li exchange of the enantiomerically enriched (88-95percent) α-tributylstannane derivative, 4.The alkylation of these lithio carbanions gave 2-methyl pyrrolidines as well as providing a measure of their configurational stability.It was found that the α-lithio formamidines were configurationally more stable than the t-BOC derivatives and this is attributed to, the stronger O-Li bond which weakens the adjacent C-Li bond, thus allowing configurational decay to occur more readily.This is the first report wherein a difference is observed between O-Li-C and N-Li-C configurational stability.
Asymmetric lithiation trapping of N -boc heterocycles at temperatures above -78°C
Gelardi, Giacomo,Barker, Graeme,O'Brien, Peter,Blakemore, David C.
, p. 5424 - 5427 (2013/11/19)
The asymmetric lithiation trapping of N-Boc heterocycles using s-BuLi/chiral diamines at temperatures up to -20°C is reported. Depending on the N-Boc heterocycle, lithiation is accomplished using s-BuLi and (-)-sparteine or the (+)-sparteine surrogate in the temperature range -50 to -20°C for short reaction times (2-20 min). Subsequent electrophilic trapping or transmetalation-Negishi coupling delivered functionalized N-Boc heterocycles in 47-95% yield and 77:23-93:7 er. With N-Boc pyrrolidine, trapped products can be generated in ~90:10 er even at -20°C.
LXR AND FXR MODULATORS
-
, (2011/03/17)
Compounds of the invention are disclosed, such as compounds of formulae LX - LXIV, and pharmaceutically acceptable salts, isomers, or prodrugs thereof, which are useful as modulators of the activity of liver X receptors (LXR) and Farnesoid X receptors (FXR), where R00, R200, R400, R500, J11, J21, G1, G21, and Q are defined herein. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.